Mari Wikman

Title: Mari Wikman: Innovator in Bioactive Peptide Production

Introduction

Mari Wikman is a prominent inventor based in Tromso, Norway. She has made significant contributions to the field of bioactive peptides, particularly in the methods of their preparation. Her innovative work has implications for therapeutic applications, especially in the treatment of tumors.

Latest Patents

Mari Wikman holds a patent for "Methods of peptide preparation." This invention relates to a method of producing a bioactive peptide that is 7 to 25 amino acids in length, containing at least 3 cationic amino acids. The peptide is capable of forming an amphipathic α-helix. The method involves identifying a cationic sector and dividing the remaining part of the peptide into three equal sectors. It also incorporates at least 60% of the bulk and lipophilicity provided by the amino acid R groups into the sectors flanking the cationic sector. The peptides produced through this method have potential uses in therapy, particularly for treating benign or malignant tumors.

Career Highlights

Mari Wikman is associated with Lytix Biopharma, where she continues to advance her research in peptide technology. Her work has garnered attention for its innovative approach to peptide design and therapeutic applications.

Collaborations

Mari collaborates with notable colleagues, including Nannan Yang and John Sigurd Svendsen. Their combined expertise contributes to the advancement of research in the field of bioactive peptides.

Conclusion

Mari Wikman's contributions to the field of bioactive peptides through her innovative methods of preparation highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.